Pathogenesis and Pathology of COVID-Associated Mucormycosis: What Is New and Why

被引:9
|
作者
Radotra, Bishan [1 ]
Challa, Sundaram [2 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Histopathol, Grp Dept C, Chandigarh 160012, India
[2] Basavatarakam Indo Amer Canc Hosp & Res Inst, Dept Pathol & Lab Med, Hyderabad 50034, Telangana, India
关键词
COVID-associated mucormycosis; Diabetes mellitus; Corticosteroids; Melanization of Mucorales hyphae; Sporangia on histopathology; FUNGAL-INFECTIONS; RHINOCEREBRAL MUCORMYCOSIS; CLINICAL-MANIFESTATIONS; INVASIVE ZYGOMYCOSIS; MELANIN; DIAGNOSIS; DISEASE; INDIA; PATHOPHYSIOLOGY; EPIDEMIOLOGY;
D O I
10.1007/s12281-022-00443-z
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of Review There is global increase in the incidence of mucormycosis. However, a sudden increase in the COVID-associated mucormycosis (CAM) was noted, particularly in India, during the second wave of the COVID-19 pandemic. The interplay of factors involved in the pathogenesis is complex. In this review, the influence of pre-existing disease, exaggerated risk factors, altered milieu due to COVID-19 itself and the consequences of its treatment on the host pathogen interactions leading to the disease and morphology of the fungus will be highlighted. Recent Findings Hyperglycemia, acidosis, available free iron, lowered host defenses, and the fungal virulence factors promote the growth of Mucorales. There is a high background prevalence of diabetes mellitus (DM) in India. Uncontrolled or undiagnosed DM, COVID-19 itself, and inappropriate administration of corticosteroids in high doses and for prolonged periods result in hyperglycemia. Diabetic ketoacidosis (DKA) and metabolic acidosis due to hypoxia or renal failure contribute to acidic pH and dissociate bound iron from serum proteins. The host defenses are lowered due to COVID-19-induced immune dysregulation, hyperglycemia itself, and administration of corticosteroids and immune suppressants for the treatment of COVID-19. The altered metabolic milieu in the local microenvironment of nose and paranasal sinuses (PNS) promotes specific interaction of glucose-regulated protein-78 (GRP-78) on host cells with spore coat protein homologue (CotH 3) on Mucorales resulting in rhino-orbito-cerebral mucormycosis (ROCM) as the predominant clinical form in CAM. The pathology is extensive soft tissue involvement with angioinvasion and perineural invasion. Melanized hyphae and sporangia were seen on histopathology, which is unique to CAM. While many factors favor the growth of Mucorales in CAM, hyperglycemia, hyperferritinemia, and administration of hyperbaric oxygen result in reactive oxygen species (ROS) and inadequate humidification results in dehydration. Melanization is possibly the adaptive and protective mechanism of Mucorales to escape the unfavorable conditions due to the treatment of COVID-19. Summary High background prevalence of DM, inappropriate administration of corticosteroids and immune dysregulation due to COVID-19 favor the growth of Mucorales in CAM. Melanization of Mucorales hyphae and sporangia on histopathology probably represent adaptive and protective mechanism due to the treatment with hyperbaric oxygen with inadequate humidification as well as the metabolic alterations.
引用
收藏
页码:206 / 220
页数:15
相关论文
共 50 条
  • [1] Pathogenesis and Pathology of COVID-Associated Mucormycosis: What Is New and Why
    Bishan Radotra
    Sundaram Challa
    [J]. Current Fungal Infection Reports, 2022, 16 : 206 - 220
  • [2] Covid-associated pulmonary mucormycosis
    Kumar, Arvind
    Palle, Mohan, V
    Asaf, Belal B.
    Puri, Harsh, V
    [J]. LUNG INDIA, 2022, 39 (02) : 100 - 101
  • [3] Additional insights on COVID-associated mucormycosis
    Panta, Prashanth
    [J]. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2022, 60 (04): : E531 - E532
  • [4] Multidisciplinary Management of COVID-Associated Mucormycosis Syndemic in India
    Rupa Mehta
    Nitin M. Nagarkar
    Atul Jindal
    Karthik Nagaraja Rao
    S. B. Nidhin
    Ripu Daman Arora
    Anil Sharma
    Archana Wankhede
    Satish Satpute
    Sharmistha Chakravarty
    N. K. Agrawal
    Pankaj Pranita
    Ajoy Kannauje
    Pugazhenthan Behera
    [J]. Indian Journal of Surgery, 2022, 84 : 934 - 942
  • [5] Central retinal artery occlusion in COVID-associated mucormycosis
    Srivastava, Smiti Rani
    Sarkar, Peyalee
    Ganguly, Purban
    Mukherjee, Debaleena
    Ray, Biman Kanti
    Dubey, Souvik
    Pandit, Alak
    Sengupta, Amitabh
    Bandopadhyay, Manimoy
    Ghosh, Asim Kumar
    Poddar, Kanika Gupta
    Guha, Soumyajit
    Ayub, Asif
    [J]. JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2023, 15 (02) : 66 - 71
  • [6] COVID-associated mucormycosis (CAM): is the Delta variant a cause?
    Arakeri, Gururaj
    Rao, U. S. Vishal
    Mendes, Rui Amaral
    Oeppen, Rachel S.
    Brennan, Peter A.
    [J]. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2022, 60 (04): : E529 - E530
  • [7] Multidisciplinary Management of COVID-Associated Mucormycosis Syndemic in India
    Mehta, Rupa
    Nagarkar, Nitin M.
    Jindal, Atul
    Rao, Karthik Nagaraja
    Nidhin, S. B.
    Arora, Ripu Daman
    Sharma, Anil
    Wankhede, Archana
    Satpute, Satish
    Chakravarty, Sharmistha
    Agrawal, N. K.
    Pranita
    Kannauje, Pankaj
    Behera, Ajoy
    Thangaraju, Pugazhenthan
    [J]. INDIAN JOURNAL OF SURGERY, 2022, 84 (05) : 934 - 942
  • [8] COVID-associated mucormycosis (CAM) in India is a multidimensional problem
    Panta, Prashanth
    Stone, Neil
    [J]. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2021, 59 (10): : 1332 - 1333
  • [9] Effectiveness of COVID-19 Vaccination against COVID-associated Mucormycosis
    Mahla, Rohit
    Shrivastava, Saurabh
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (11) : EC9 - EC11